Altimetric growth, J&J, FedEx and more

Check out the companies that make news before the bell:

Altimeter Growth (AGC) – The Southeast Asian giant Grab will be made public through a SPAC merger with Altimeter Growth, valued at about $ 40 billion. Grab says he intends to appear on the Nasdaq with the symbol “GRAB” after the deal ends. Altimeter shares rose nearly 9% in pre-market trading.

Johnson & Johnson (JNJ) – Drug maker’s shares fell 2.8% in the pre-market after the Food and Drug Administration said it was asking states to pause the administration of J&J’s Covid-19 vaccine after that six people in the United States have developed an uncommon disorder that affects blood clots. The FDA said the recommendation is “for great caution.” Shares of Moderna appeared more than 7% in the initial news trading.

FedEx (FDX): The shipping company’s shares rose in premarket trading on KeyBanc Capital Markets which FedEx changed to “overweight”. The Wall Street firm also set a target of $ 350 per share on FedEx. KeyBanc said FedEx can still increase volume even with the return on face-to-face purchases.

JetBlue (JBLU), Spirit Airlines (SAVE): The shares of the airlines appeared in the premarket trade after Susquehanna Financial Group upgraded JetBlue and Spirit Airlines to “positive”. “With a recovery of U.S. domestic air travel underway, we want to own low-cost airlines,” he told analysts at the firm.

Booking Holdings (BKNG): Travel company won in premarket trade after Jefferies upgraded Booking to “buy” from “hold back” a rise in global travel. The former also raised its 12-month price target to $ 2,800 per share, from $ 2,300 per share.

3M (MMM): Shares of the manufacturing giant went down in the pre-market after Deutsche Bank added a “catalytic call” sale to 3M. The Wall Street firm said shares have curiously outperformed in recent weeks despite Deutsche Bank’s expectation of losing the next gains.

NortonLifeLock (NLOK): The security company fell pre-market trading after Bank of America launched the shares with a rating of “low yield” and a target of $ 19 per share. “Last year’s increase in demand related to COVID may relax in the coming quarters and the company may return to negative trends in the incorporation of subscriptions and subscriptions, negatively affecting revenue growth,” the signature.

Honeywell (HON) – Honeywell shares rose in premarket trading after Deutsche Bank put a “catalyst” buyout. The firm said investors are not enthusiastic about Honeywell, despite the recovery.

Bristol-Myers Squibb (BMY) – The pharmaceutical company’s shares rose in the pre-market on Truist which upgraded Bristol-Myers Squibb to “buy” from “hold” with a target price of $ 74 per share. The Wall Street firm said it likes the Bristol-Myers Squibb drug pipeline.